SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Inc. (“ZYUS”), a company focused on the global development and commercialization of innovative cannabinoid-based formulations and product candidates, and Pure Sunfarms Corp. (“Pure Sunfarms”), one of Canada’s largest producers of greenhouse-grown cannabis, are pleased to announce they have entered into a three-year Supply Agreement (the “Agreement”) for ZYUS to purchase high-quality dried cannabis raw material from Pure Sunfarms.

The Agreement with Pure Sunfarms will provide an additional source of raw material for ZYUS’ extraction process and the development and production of a range of cannabinoid-based formulations for the medical market including gel-caps, oils and topicals.

“Quality is at the center of everything we do at ZYUS,” said ZYUS CEO, Brent Zettl. “When selecting partners to supply us with raw material for our formulations, we looked for companies that shared our commitment to quality, meeting GMP requirements, and maintaining the highest level of integrity across the organization. We feel that Pure Sunfarms is completely aligned with us in these areas and we look forward to partnering with them as a supplier as we help improve patient outcomes both here in Canada and around the world.”

“This Supply Agreement with ZYUS is an important milestone for Pure Sunfarms,” said Mandesh Dosanjh, President and CEO, Pure Sunfarms. “We are proud to be recognized across the industry for our high-quality greenhouse-grown cannabis and ability to produce a consistent product. By partnering with ZYUS, we will be supporting at the forefront of medical research and innovation in cannabis, and we look forward to being part of the transformational impact that cannabinoids can have on the lives of patients.”

About ZYUS Life Sciences Inc.

ZYUS is a Canadian-based life sciences company focused on the global development and commercialization of innovative cannabinoid-based therapeutics and product candidates. Through clinical research and IP development, we intend to deliver high-quality oils, gel-caps, topical creams and other cannabinoid-based therapeutics and product candidates to patients worldwide. The ZYUS vision is to elevate cannabinoids as a standard of care and expand the potential of protein-based formulations in pursuit of a transformational impact on patients’ lives. ZYUS: Advancing the Science of Well-Being. Visit www.zyus.com

About Pure Sunfarms

Pure Sunfarms is one of Canada’s largest, single site, licensed producers of greenhouse-grown cannabis. Located in Delta, British Columbia, Pure Sunfarms is a vertically integrated supplier of large-scale, high-quality cannabis to the Canadian market. With more than 25 years of growing experience and 1.1 million square feet of best-in-class greenhouse operations, the company produces 75,000 kilograms of dried flower annually.

Pure Sunfarms is a joint venture between Village Farms International, Inc. and Emerald Health Therapeutics Inc. www.puresunfarms.com

Forward-Looking Information

This news release contains forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of ZYUS to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These forward-looking statements include, but are not limited to expectations with respect to our business plans and product lines.

Often, but not always, forward-looking statements can be identified by the use of words such as “expects,” “expected,” “expectation,” “anticipates,” “believes,” “intends,” “estimates,” “predicts,” “continues,” “potential,” “targeted,” “plans,” “possible” and similar expressions, or statements that events, conditions or results “will,” “may,” “could,” “would” or “should” occur or be achieved, or the negative of these terms or other comparable terminology. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements.

Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this press release. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties.

Actual results could differ materially from those currently anticipated due to a number of factors and risks. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward-looking statements contained in this news release are made as of the date of this release and, accordingly, are subject to change after such date. ZYUS does not assume any obligation to update or revise any forward-looking statements, whether written or oral, that may be made from time to time by us or on our behalf, except as required by applicable law.